At what price was the SiriusPoint (SPNT) share grant to Sharon M. Ludlow recorded?

The 5,903 Common Shares granted to Sharon M. Ludlow were recorded at $23.29 per share. This figure is for reporting purposes and reflects the value used to disclose the equity award in the insider transaction filing.

SiriusPoint director granted 5,903 common shares

Ludlow Sharon M reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 05/29/2026 - 04:43 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Ludlow Sharon M reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Sharon M. Ludlow reported receiving a grant of 5,903 Common Shares of the company on May 29, 2026, recorded at $23.29 per share. This is a compensation-related award, not an open‑market purchase.

After this grant, Ludlow directly holds 160,693 Common Shares, which include restricted shares. The footnotes state that some of these restricted shares will vest in full on May 30, 2027, if she continues to serve as a director through that date.

Insider Trade Summary

Grant/Award: 5,903 shares

Grant/Award 1 txn

Insider Ludlow Sharon M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	5,903	$23.29	$137K

Holdings After Transaction: Common Shares — 160,693 shares (Direct)

Footnotes (2)

F1. Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company.
F2. Includes Restricted Shares.

Key Figures

Share grant size: 5,903 shares Grant reference price: $23.29 per share Post‑grant holdings: 160,693 shares +1 more

4 metrics

Share grant size 5,903 shares Common Shares granted to director on May 29, 2026

Grant reference price $23.29 per share Recorded price for the 5,903-share equity award

Post‑grant holdings 160,693 shares Total Common Shares held directly after transaction

Restricted share vesting date May 30, 2027 Restricted shares vest if director service continues

Key Terms

Restricted Shares, Common Shares, grant/award acquisition

3 terms

Restricted Shares financial

"Includes restricted shares that vest in full on May 30, 2027"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Common Shares financial

"Common Shares, transaction_shares 5903.0000, price per share 23.2900"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

grant/award acquisition financial

"transaction_action: grant/award acquisition, transaction_code_description"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SiriusPoint (SPNT) director Sharon M. Ludlow report?

Sharon M. Ludlow reported receiving a grant of 5,903 SiriusPoint Common Shares. The award is categorized as a grant or other acquisition, reflecting equity compensation for board service rather than an open-market stock purchase or sale.

How many SiriusPoint (SPNT) shares does Sharon M. Ludlow hold after this grant?

Following the reported grant, Sharon M. Ludlow directly holds 160,693 SiriusPoint Common Shares. This total includes restricted shares that have not yet vested and are subject to continued service on the company’s board of directors.

When do Sharon M. Ludlow’s restricted SiriusPoint (SPNT) shares vest?

The filing notes that certain restricted SiriusPoint shares held by Sharon M. Ludlow vest in full on May 30, 2027. Vesting is conditional on her continued service as a director through that date, aligning the award with long-term board tenure.

Is the SiriusPoint (SPNT) Form 4 transaction a market buy or sell?

The Form 4 transaction is not a market buy or sell; it is a grant or award acquisition. Shares were received as part of compensation, rather than purchased or sold in the open market, which typically carries different signaling implications for investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ludlow Sharon M

(Last)

(First)

(Middle)

POINT BUILDING, 3 WATERLOO LANE

(Street)

PEMBROKE

HM 08

(City)

(State)

(Zip)

BERMUDA

(Country)

2. Issuer Name and Ticker or Trading Symbol
SiriusPoint Ltd [ SPNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	05/29/2026		A		5,903⁽¹⁾	A	$23.29	160,693⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company.

2. Includes Restricted Shares.

Remarks:

Exhibit 24-Power of Attorney

	/s/ Jacquelyne Belcastro, as Attorney-in-Fact for Sharon M. Ludow	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR